Trial intelligence / Profile preview

VASCALB: Albumin 20% vs 5% vs Ringer's Lactate in Cystectomy

NCT05391607Phase 4Completed

Sponsor
Insel Gruppe
Start
May 2022
Primary completion
Mar 2023
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of albumin (human) in hemorrhage, sponsored by Insel Gruppe. Started May 2022; status: completed.

02

Drugs

albumin (human)
03

Conditions

hemorrhage

Beyond the preview

Go deeper on NCT05391607.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05391607.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call